Springworks Therapeutics Inc (SWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -58,306 | -17,813 | N/A | 9,790 | 5,660 |
| Depreciation Amortization | 192 | 17 | N/A | 2,810 | 2,590 |
| Accounts payable and accrued liabilities | 1,880 | 491 | N/A | N/A | N/A |
| Other Working Capital | 4,947 | 2,561 | N/A | -2,590 | -1,030 |
| Other Operating Activity | 3,843 | 578 | 0 | -4,410 | -2,000 |
| Operating Cash Flow | $-47,444 | $-14,166 | $N/A | $5,600 | $5,220 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -670 | -293 | N/A | -1,880 | -1,690 |
| Net Acquisitions | N/A | N/A | N/A | -3,490 | 0 |
| Purchase Of Investment | -3,590 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | -10 | 260 |
| Investing Cash Flow | $-4,260 | $-293 | $N/A | $-5,380 | $-1,430 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 21 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 333,687 | 50,376 | 0 | 990 | -1,960 |
| Financing Cash Flow | $333,708 | $50,376 | $N/A | $990 | $-1,960 |
| Exchange Rate Effect | N/A | N/A | N/A | 100 | -140 |
| Beginning Cash Position | 46,188 | 10,271 | N/A | 12,450 | 10,760 |
| End Cash Position | 328,192 | 46,188 | N/A | 13,770 | 12,450 |
| Net Cash Flow | $282,004 | $35,917 | $N/A | $1,320 | $1,680 |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,444 | -14,166 | N/A | 5,600 | 5,220 |
| Capital Expenditure | -670 | -293 | N/A | N/A | N/A |
| Free Cash Flow | -48,114 | -14,459 | 0 | 5,600 | 5,220 |